Skip to main content

Peer Review reports

From: A prospective observational cohort study of lenvatinib as initial treatment in patients with BCLC-defined stage B hepatocellular carcinoma

Original Submission
13 Mar 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
4 Apr 2022 Reviewed Reviewer Report
4 Apr 2022 Reviewed Reviewer Report - Alessandro Granito
19 Apr 2022 Author responded Author comments - Satoshi Kobayashi
Resubmission - Version 3
19 Apr 2022 Submitted Manuscript version 3
26 Apr 2022 Reviewed Reviewer Report - Alessandro Granito
27 Apr 2022 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
27 Apr 2022 Editorially accepted
7 May 2022 Article published 10.1186/s12885-022-09625-x

You can find further information about peer review here.

Back to article page